Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe Immunotherapy

Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for ImmunotherapyПодробнее

Accelerating T Cell Therapy ResearchПодробнее

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle PlatformПодробнее

A platform for automated functionalization of lipid nanoparticles for CAR T cell therapyПодробнее

Insights on Lipid Nanoparticle Delivery and Scalable Microfluidic ManufacturingПодробнее

The Wider Use Of mRNA To Treat Various Forms Of Cancer & Autoimmune DiseasesПодробнее

Flexible, clinically adaptable, non-viral approaches to CAR TCR methodologiesПодробнее

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell TherapyПодробнее

AbLearning™ - Episode 3: Chimeric Antigen Receptor T Cell TherapyПодробнее

CAR-T and CAR-NK Cell Therapy DevelopmentПодробнее

In vivo mRNA Delivery to Antigen-specific T cells by Antigen-presenting NanoparticlesПодробнее

T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapyПодробнее

Achieving mRNA-LNP Delivery Beyond the LiverПодробнее

"Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gairdner WeekПодробнее

Microfluidics in manufacturing of mRNA Nanomedicines | Heinrich Haas, BioNTechПодробнее

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid NanoparticlesПодробнее

Development of mRNA and its ApplicationsПодробнее

Jonathan Epstein - mRNA-mediated Immunotherapy for Heart FailureПодробнее